Pandion Therapeutics Inc. (PAND1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Rahul Kakkar
Employees:
43
134 COOLIDGE AVENUE, 2ND FLOOR, WATERTOWN, MA 02472
617-393-5925

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

We are a clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases.

Data derived from most recent annual or quarterly report
Market Cap 1.772 Billion Shares Outstanding29.516 Million Avg 30-day Volume 266.352 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-3.17
Price to Revenue49.9267 Debt to Equity0.0 EBITDA-37.417 Million
Price to Book Value2.0412 Operating Margin-432.0424 Enterprise Value218.415 Million
Current Ratio25.287 EPS Growth0.873 Quick Ratio24.937
1 Yr BETA -1.829 52-week High/Low 0.0 / Profit Margin-434.0472
Operating Cash Flow Growth-160.5406 Altman Z-Score20.1168 Free Cash Flow to Firm -29.505 Million
View SEC Filings from PAND1 instead.

View recent insider trading info

Funds Holding PAND1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PAND1

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2021-04-01:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-02-25:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-01-04:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-12-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BELOFF GREGG SEE REMARKS

    • Officer
    No longer subject to file 2021-04-01 0

    CRANE ALAN L

    • Director
    • 10% Owner
    No longer subject to file 2021-04-01 0

    FUGLESANG CHRISTOPHER

    • Director
    • 10% Owner
    No longer subject to file 2021-04-01 0

    CARROLL JILL

    • Director
    • 10% Owner
    No longer subject to file 2021-04-01 0

    DORTON KATINA

    • Director
    No longer subject to file 2021-04-01 0

    LARSON ERIC D VICE PRESIDENT, FINANCE

    • Officer
    No longer subject to file 2021-04-01 0

    GOYAL VIKAS SEE REMARKS

    • Officer
    No longer subject to file 2021-04-01 0

    BECKER DANIEL J.

    • Director
    No longer subject to file 2021-04-01 0

    VINEY JOANNE L. SEE REMARKS

    • Officer
    No longer subject to file 2021-04-01 0

    CARLO RIZZUTO

    • Director
    No longer subject to file 2021-04-01 0

    SUNDY JOHN CHIEF MEDICAL OFFICER

    • Officer
    No longer subject to file 2021-04-01 0

    KAKKAR RAHUL CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    No longer subject to file 2021-04-01 0

    FREEDMAN EDWARD D. CHIEF OPERATING OFFICER

    • Officer
    No longer subject to file 2021-04-01 0

    STAGLIANO NANCY

    • Director
    No longer subject to file 2021-04-01 0

    FRAIL DONALD

    • Director
    No longer subject to file 2021-04-01 0

    MERCK & CO., INC.

    MERCK SHARP & DOHME CORP.

    • 10% Owner
    0 2021-02-24 0

    ROCHE HOLDING LTD

    ROCHE FINANCE LTD

    • 10% Owner
    3,086,084 2020-07-21 0

    BOXER CAPITAL, LLC

    BOXER ASSET MANAGEMENT INC.

    BRASLYN LTD.

    LEWIS JOSEPH

    DAVIS AARON I.

    MVA INVESTORS, LLC

    • 10% Owner
    No longer subject to file 2020-07-21 0

    RA CAPITAL MANAGEMENT, L.P.

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • 10% Owner
    No longer subject to file 2020-07-21 0

    POLARIS PARTNERS GP VIII, L.L.C.

    POLARIS ENTREPRENEURS' FUND VIII, L.P.

    POLARIS PARTNERS VIII, L.P.

    • 10% Owner
    3,201,422 2020-07-21 0

    VERSANT VENTURE CAPITAL VI, L.P.

    VERSANT VANTAGE I, L.P.

    VERSANT VENTURES VI GP, L.P.

    VERSANT VENTURES VI GP-GP, LLC

    VERSANT VANTAGE I GP, L.P.

    VERSANT VANTAGE I GP-GP, LLC

    • 10% Owner
    3,754,051 2020-07-21 0

    MUTZ MITCHELL

    • Director
    • 10% Owner
    3,096,084 2020-07-21 0

    JDRF T1D FUND LLC

    • 10% Owner
    426,333 2020-07-21 0

    GLAXOSMITHKLINE PLC

    • Director
    • 10% Owner
    2,248,304 2020-07-17 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP VII LLC

    ORBIMED GENESIS GP LLC

    • 10% Owner
    0 2020-07-16 0

    ACCESS INDUSTRIES HOLDINGS LLC

    AI PAN LLC

    ACCESS INDUSTRIES MANAGEMENT, LLC

    BLAVATNIK LEN

    • 10% Owner
    0 2020-07-16 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    PANDION THERAPEUTICS INC PAND 2021-04-01 22:15:03 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 21:45:03 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 21:15:03 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 20:45:03 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 20:15:03 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 19:45:03 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 19:15:02 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 18:45:03 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 18:15:03 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 17:45:03 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 17:15:03 UTC -1.0115 1.0615 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 16:45:03 UTC -1.0132 1.0832 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 16:15:03 UTC -1.0132 1.0832 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 15:45:04 UTC -1.0132 1.0832 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 15:15:03 UTC -1.0132 1.0832 100000
    PANDION THERAPEUTICS INC PAND 2021-04-01 14:45:03 UTC -1.0132 1.0832 85000
    PANDION THERAPEUTICS INC PAND 2021-04-01 14:15:02 UTC -1.0132 1.0832 85000
    PANDION THERAPEUTICS INC PAND 2021-04-01 13:45:03 UTC -1.0132 1.0832 85000
    PANDION THERAPEUTICS INC PAND 2021-04-01 13:15:02 UTC -1.0132 1.0832 700
    PANDION THERAPEUTICS INC PAND 2021-04-01 12:45:03 UTC -1.0132 1.0832 700

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments